Business Wire

French Ministry of the Interior Selects IDEMIA and Sopra Steria to Develop a New Standard Border Control System

29.1.2021 10:30:00 EET | Business Wire | Press release

Share

CCAF is an ambitious project seeking to install a high-performance standard system so that all border control activities can be properly coordinated and harmonized. It will be rolled out in France during 2021.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210128005909/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

(Photo: Business Wire)

While assuring border controls’ underlying need for security and accuracy, CCAF’s development will also focus on interoperability and scalability. It will be so designed that it can cope with future French and EU regulatory changes and growth in traveller traffic in and out of mainland and overseas France.

Underpinned by biometric recognition, the system will minimize traveller time spent passing through border controls without having to hire further guards on French borders.

IDEMIA and Sopra Steria will join forces tapping into their ID management expertise, especially in relation to border security, and their French critical systems in-depth know-how.

There is a lot at stake with the CCAF project including a need to factor in high flexibility and responsiveness when developing EU IT systems in view of upcoming world sports events like the 2023 Rugby World Cup and the 2024 Paris Olympics. With this joint project, the Ministry placed their trust in the consortium’s skill and expertise in meeting highly demanding business, tech and regulatory needs and tight milestone deadlines.

“We are very grateful to the French Ministry of the Interior for having trusted our know-how and expertise in automated border-crossing controls. The CCAF project aims to develop and perfect a standard and robust border system that is both smoother and more secure. Together with our partner Sopra Steria, we pledge to provide a groundbreaking system that delivers a high level of security and an enhanced travel experience.” said Pascal Fallet, IDEMIA Senior VP Europe, Public Security and Identity.

“Having served the Ministry of the Interior over many years, we are immensely proud to be selected with our partner IDEMIA to develop and roll out the new standard border control system. IDEMIA’s skills and know-how as biometrics world leader fit very well with our own skills as reputed big government systems integrator in complex environments. This will be a great asset to ensure the project’s success. Together with IDEMIA we pledge to develop a reliable and secure system that sustainably delivers on required service quality by harnessing all necessary state-of-the-art technologies.” said Georges Wakim, Sopra Steria Security Market Director.

In France, IDEMIA is currently responsible for the passenger automated border control tracking system and the visa and asylum application data processing system. IDEMIA also regularly conducts pilot tests with various private and public sector parties including Aéroports de Paris (ADP Group), Air France and recently Lyon Aéroports (MONA by Vinci Airports) with a view to biometrics improving the airport’s passenger experience.

Meanwhile, Sopra Steria frequently serves the French Ministry of the Interior bringing many famous projects to fruition. For instance, the Group helps develop the Schengen border system working with various other EU Member States, develops and delivers security file search apps for French police forces and works to enhance French road safety and management of foreign migrants.

Last June, IDEMIA and Sopra Steria were picked by EU agency eu-LISA to develop the new shared Biometric Matching System (sBMS), on which Schengen Area border security is based.

About IDEMIA

IDEMIA, the global leader in Augmented Identity, provides a trusted environment enabling citizens and consumers alike to perform their daily critical activities (such as pay, connect and travel), in the physical as well as digital space.

Securing our identity has become mission critical in the world we live in today. By standing for Augmented Identity, an identity that ensures privacy and trust and guarantees secure, authenticated and verifiable transactions, we reinvent the way we think, produce, use and protect one of our greatest assets – our identity – whether for individuals or for objects, whenever and wherever security matters. We provide Augmented Identity for international clients from Financial, Telecom, Identity, Public Security and IoT sectors. With close to 15,000 employees around the world, IDEMIA serves clients in 180 countries.

For more information, visit www.idemia.com / Follow @IDEMIAGroup on Twitter

About Sopra Steria

Sopra Steria, a European leader in consulting, digital services and software development, helps its clients drive their digital transformation and obtain tangible and sustainable benefits. It provides end-to-end solutions to make large companies and organisations more competitive by combining in-depth knowledge of a wide range of business sectors and innovative technologies with a fully collaborative approach. Sopra Steria places people at the heart of everything it does and is committed to putting digital to work for its clients in order to build a positive future for all. With 46,000 employees in 25 countries, the Group generated revenue of €4.4 billion in 2019.

The world is how we shape it.

Sopra Steria (SOP) is listed on Euronext Paris (Compartment A) – ISIN: FR0000050809

To learn more, go to https://www.soprasteria.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Press contacts
IDEMIA:
Hanna SEBBAH
idemia@havas.com
+33 (0) 6 63 73 30 30

Sopra Steria :
Elsa ESTAGER
elsa.estager@soprasteria.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Brenus Pharma Announces FDA Acceptance of IND Application for STC-1010 (BreAK-CRC001) in MSS Metastatic Colorectal Cancer (mCRC)27.5.2026 09:49:00 EEST | Press release

Brenus Pharma, a clinical stage biotechnology company developing novel in vivo immunotherapies for solid tumors, announced that the U.S. Food and Drug Administration (FDA) has accept the company's Investigational New Drug (IND) application for its first drug candidate, STC-1010, in microsatellite stable (MSS) metastatic colorectal cancer (mCRC). STC-1010 is designed to address a critical unmet need worldwide. Approximately 95% of mCRC patients have MSS tumors, which demonstrate minimal response to standard immunotherapies. The FDA validated Brenus Pharma's advanced regulatory and manufacturing capabilities. This operational readiness will accelerate patient access and data generation across both European and US sites for a Phase II program planned for 2027. "FDA's acceptance of our IND represents a major validation of our program and enables the full execution of our clinical strategy across Europe and the United States. Achieving regulatory alignment across multiple jurisdictions refl

Alfasigma presents first data on filgotinib from the Phase 3 OLINGUITO trial in axial spondyloarthritis at EULAR 202627.5.2026 09:00:00 EEST | Press release

Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare and specialty care where there is significant unmet patient need, presented positive results from the OLINGUITO Phase 3 clinical trial (NCT05785611iEudraCT 2022-501354-10-01ii) at EULAR 2026. In OLINGUITO filgotinib, an oral, once-daily JAK1 preferential inhibitor under investigation for the treatment of adult patients with active axial spondyloarthritis (axSpA), demonstrated sustained improvements in the signs and symptoms of axSpA, including disease activity and inflammation.iii Safety was consistent with the known profile of filgotinib, indicating a favourable benefit-risk profile for patients with active axSpA.iii The OLINGUITO trial consists of two international, randomised, double-blind, placebo-controlled studies (Study A and Study B), evaluating the efficacy and safety of filgotinib 200mg once-daily vs. placebo in patients with an established diagnosis of axSpA as per ASAS classification.i Eligi

Tide Crosses 2 Million Members Worldwide - Big Step Forward in Mission to Support and Grow Small Businesses27.5.2026 09:00:00 EEST | Press release

Tide, the UK’s leading business management platform, today announces it has crossed 2 million members globally, with India in particular seeing strong growth. More than 1.1 million small businesses joined Tide in India since the company launched there in December 2022. This makes India Tide’s fastest-growing market by member acquisition. The UK is Tide’s home market, with 900,000 SMEs, 15% market share, and the majority of the company’s revenue. Tide’s steadily expanding its presence in Europe, with Germany and France, where the platform is gaining strong traction, thanks to millions of small businesses turning to digital to manage their businesses. In late 2025, Tide received a strategic investment from TPG, a leading global alternative asset manager, valuing the company at $1.5 billion. Oliver Prill, CEO of Tide, said: “We are delighted to be crossing the 2 million member milestone. This number is a testament to the trust that our members place in us in all our markets. Behind every

Royal London Asset Management Expands Relationship with SS&C to Service New Australian Funds27.5.2026 01:00:00 EEST | Press release

SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that Royal London Asset Management, a leading U.K. fund management company, has extended its relationship with SS&C. SS&C Global Investor & Distribution Solutions will provide fund administration and unit registry services for its new range of Australian active funds, including: Royal London Global Equity Diversified Fund Royal London Global Equity Enhanced Fund Royal London Global Equity Select Fund Royal London Short Duration Global High Yield Bond Fund RLAM is part of Royal London, the U.K.’s largest mutual life, pensions and investment company. SS&C services approximately £72bn in assets under management across its U.K. fund range. Equity Trustees will serve as the Responsible Entity for RLAM’s new funds, which have launched with around AUD $1 billion in AUM. The unit trusts are structured as feeder funds, providing investors with indirect exposure to RLAM’s range of Dublin-domiciled Undertakings for Collective Investm

SLB Announces Date for Second-Quarter 2026 Results Conference Call26.5.2026 20:00:00 EEST | Press release

SLB (NYSE: SLB) will hold a conference call on July 24, 2026, to discuss the results for the second quarter ending June 30, 2026. The conference call is scheduled to begin at 9:30 a.m. U.S. Eastern time and a press release regarding the results will be issued at 7:00 a.m. U.S. Eastern time. To access the conference call, listeners should contact the Conference Call Operator at +1 (800) 715-9871 within North America or +1 (646) 307-1963 outside of North America approximately 10 minutes prior to the start of the call and the access code is 3440360. A webcast of the conference call will be broadcast simultaneously at https://events.q4inc.com/attendee/157027565 on a listen-only basis. Listeners should log in 15 minutes prior to the start of the call to test their browsers and register for the webcast. Following the end of the conference call, a replay will be available at www.slb.com/irwebcast until July 31, 2026, and can be accessed by dialing +1 (800) 770-2030 within North America or +1

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye